Treatment with sorafenib demonstrated significantly increased growth inhibition of the ACHN/sh‐Akt1 tumor. The apoptotic index in ACHN/sh‐Akt1 tumor was found to be significantly increased than ACHN/C tumor when treated with sorafenib liposomes. The gene discussed is AKT1; the disease is neoplasm.